VTCN1 and ovarian serous carcinoma: The relationship between B7-H4 expression and clinicopathologic factors, and the effect of B7-H4 on survival rate also were also investigated to determine the clinical significance and the potential of B7-H4 as a therapeutic target for ovarian serous carcinoma.